Delivery Order #SPE2DR26F6H72

Delivery Order for Novolog Insulin Vials under AmerisourceBergen IDV

This award represents a delivery order contract issued under an existing indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corp, a prominent pharmaceutical distributor specializing in medication and healthcare product procurement. The contract procures a specific pharmaceutical product, Novolog insulin in 100 unit/ml 10ml vials, highlighting its role in supporting diabetes management within government healthcare programs. The delivery order signifies a focused, short-term fulfillment of medication supply critical to maintaining consistent treatment availability. This acquisition follows a competitive procurement process established by the parent IDV, emphasizing efficiency and responsiveness in pharmaceutical services. The scope involves the timely delivery of the specified insulin product to the designated location in Conshohocken, Pennsylvania. The contract's performance period is brief, spanning a couple of days in early 2026, reflecting its nature as a single delivery action within the overarching supply agreement. This award underscores the ongoing collaboration between government agencies and AmerisourceBergen to sustain essential pharmaceutical supply chains.

Description

4571084209!NOVOLOG 100 UNIT/ML VIAL 10ML

View original record